Author Archives

There is a stock I would like reviewed and I don’t think I know how to send it on the web site. It is up about 200% since I took a position within the last 10 days. It is a techno medical stock that will enable the POC (point of contact) analysis to test whether […]

Well Travis I have a conundrum for you as I look at the landscape of newsletters and what is being hawked today. So I am not asking advice on my portfolio, but your take on which way the wind is blowing. Here’s what I see: Jim Rickards (Agora) is promoting gold in discriminate amounts according […]

Recent Author Comments

We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

More Info